Navigation Links
Amicus Therapeutics Announces Second Quarter 2009 Financial Results
Date:8/5/2009

ones and receipt of milestone payments from Shire. Additionally, all forward looking statements are subject to other risks detailed in our Annual Report on Form 10-K for the year ended December 31, 2008, and our other public filings with the Securities and Exchange Commission. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement, and Amicus undertakes no obligation to revise or update this news release to reflect events or circumstances after the date hereof. This caution is made under the safe harbor provisions of Section 21E of the Private Securities Litigation Reform Act of 1995.

FOLD-G

     Table 1
                            Amicus Therapeutics, Inc.
                          (a development stage company)
                      Consolidated Statements of Operations
                                   (Unaudited)
                (In thousands, except share and per share amounts)


                                                                   Period from
                                                                   February 4,
                                                                       2002
                                                                   (inception)
                              Three Months          Six Months          to
                             Ended June 30,        Ended June 30,    June 30,
                             2008      2009        2008      2009      2009

    Revenue:
      Research revenue     $3,113     $4,667     $5,579     $8,580   $22,143
      Collaboration
       revenue                694        694      1,389      1,389     4,576
    Total revenue           3,807      5,361      6,968      9,969    26,719

    Operating Expenses:
      Research and
       development         
'/>"/>
SOURCE Amicus Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotech & Medtech 2007 Conference
2. Amicus Therapeutics Announces Third Quarter 2007 Financial Results
3. Meredith Martin Addy Named Chair of AIPLAs Amicus Committee
4. Amicus Therapeutics to Present at the Lazard Capital Markets Fourth Annual Healthcare Conference
5. Amicus Therapeutics to Host R&D Day
6. Amicus Therapeutics Announces Positive Results From Phase 2 Clinical Trials of Amigal(TM) for Fabry Disease
7. Amicus Therapeutics Announces Fourth Quarter and Full Year 2007 Financial Results & Program Advancements
8. Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
9. Amicus Therapeutics to Present at the BIO CEO & Investor Conference 2008
10. Amicus Therapeutics Presents Positive Data from Phase 2 Clinical Trial of Plicera(TM) for Gaucher Disease
11. Amicus Therapeutics to Present at the Morgan Stanley Global Healthcare Unplugged Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... Rootstown, OH (PRWEB) January 22, 2015 Crystal ... announced today that it has received AOAC-PTM Certifications for the ... O111, O121, and O145; collectively referred to as STEC or ... at 1 colony forming unit (cfu) per 325 g of ...
(Date:1/22/2015)... Madison, WI (PRWEB) January 22, 2015 Dr. ... at the 12th annual Scripps Natural Supplements Pre-Conference seminar on ... Supplements Conference is an annual continuing education conference for health ... 15th and included the topic of probiotics in health. Dr. ...
(Date:1/22/2015)... 22, 2015 Diagenode, Inc., a ... the Bioruptor® and complete solutions for epigenetics research, ... immunoprecipitation, alleviating the need for manual processing. The ... for ChIP of histones or transcription factors and ...
(Date:1/22/2015)... PALO ALTO, Calif. , Jan. 22. 2015  Varian Medical ... equipment and software, has been honored for its commitment to ... most sustainable companies. Varian is the highest ranked healthcare equipment ... ranking, announced today during the World Economic Forum at ...
Breaking Biology Technology:Crystal Diagnostics Awarded AOAC-PTM Accreditation for the Rapid Detection of “Big 6” E.coli Food Pathogens 2Diagenode Launches Unique Semi-Automated Solution for Chromatin Immunoprecipitation 2Varian Honored Among World's 100 Most Sustainable Corporations 2
... Illumination of a Critical Regulation Pathway , of Protein Expression , ... MicroRNAs (miRNAs) are a recently identified , ... expression at the , ... single-stranded RNA molecules expressed in eukaryotic cells , ...
... A variety of siRNA applications, including , ... hundreds to thousands of siRNAs to cells. Most published siRNA ... in 6 well and 24 , ... NeoFX Transfection Agent and siPORT siRNA , ...
... mir Vana miRNA Probe Set and mir Vana , miRNA Labeling Kit , ... Detecting miRNAs on Microarrays , ... species that represent approximately 0.01% of the total mass , ... to their small size and low abundance, ...
Cached Biology Technology:Getting Started with MicroRNA Research 2Getting Started with MicroRNA Research 3Getting Started with MicroRNA Research 4Getting Started with MicroRNA Research 5Getting Started with MicroRNA Research 6Getting Started with MicroRNA Research 7Getting Started with MicroRNA Research 8Getting Started with MicroRNA Research 9High Throughput siRNA Delivery In Vitro: From Cell Lines to Primary Cells 2High Throughput siRNA Delivery In Vitro: From Cell Lines to Primary Cells 3High Throughput siRNA Delivery In Vitro: From Cell Lines to Primary Cells 4High Throughput siRNA Delivery In Vitro: From Cell Lines to Primary Cells 5High Throughput siRNA Delivery In Vitro: From Cell Lines to Primary Cells 6High Throughput siRNA Delivery In Vitro: From Cell Lines to Primary Cells 7High Throughput siRNA Delivery In Vitro: From Cell Lines to Primary Cells 8High Throughput siRNA Delivery In Vitro: From Cell Lines to Primary Cells 9High Throughput siRNA Delivery In Vitro: From Cell Lines to Primary Cells 10Highly Sensitive microRNA Array Performance 2Highly Sensitive microRNA Array Performance 3Highly Sensitive microRNA Array Performance 4Highly Sensitive microRNA Array Performance 5Highly Sensitive microRNA Array Performance 6Highly Sensitive microRNA Array Performance 7Highly Sensitive microRNA Array Performance 8
(Date:1/22/2015)... MELBOURNE, Fla. , Jan. 13, 2015  Today, ... wearable technology, launched its crowdfunding campaign on Fundable, ... accelerate the build of production capacity to meet ... Photo - http://photos.prnewswire.com/prnh/20150113/168790 ...
(Date:1/22/2015)... , Jan. 16, 2015  A man-made form of insulin ... other mental capabilities in adults with mild cognitive impairment ... led by researchers at Wake Forest Baptist Medical Center. ... with amnesic mild cognitive impairment (MCI) or mild to ...
(Date:1/22/2015)... Jan. 21, 2015  Analyst Report Issued by Small Cap IR. ... showed that planet-wide, transactions at merchants on the leading payment ... number of credit, debit, and prepaid cards reached 6.54 billion.  ... of fraudulent card usage in 2012, and credit and debit ...
Breaking Biology News(10 mins):FreeWavz Launches on Fundable to Drive Speed-to-Market in 2015 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 3$4.80 Near Term Price Target with "Buy" given by CapRock Research for NXT-ID, Inc. (NASDAQ: NXTD) issued by Small Cap IR 2
... High-tech laboratory tools, like computers, are often updated publicly ... issue of the Journal of Molecular Diagnostics, NIH grantees ... a silicon chip" called the MitoChip v2.0 that for ... DNA. Mitochondria, the energy-producing organelles that power our ...
... of dairy cows, may not be so harmless after ... resistance genes that can be transferred to more harmful, ... 106th General Meeting of the American Society for Microbiology ... therapeutic usage of antibiotics in animals is responsible for ...
... crimini mushrooms rank with carrots, green beans, red peppers ... State researchers say. , Dr. N. Joy Dubost, who ... State, measured the activity of two antioxidants, polyphenols and ... HPLC instrumentation, as part of her dissertation research. She ...
Cached Biology News:Mitochondrial DNA sequencing tool updated 2Mitochondrial DNA sequencing tool updated 3Mitochondrial DNA sequencing tool updated 4Mushrooms as good an antioxidant source as more colorful veggies 2